Australia revises controversial pre-market device assessment plans
This article was originally published in SRA
Executive Summary
Australia's Therapeutic Goods Administration has revised its controversial proposals to strengthen the pre-market assessment of medical devices and improve the transparency of it decision making process in light of concerns from the medtech industry1,2. The proposals relate to mandatory application audits, transparency and third-party assessment.